Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.21.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]    
Revenues $ 114,453 $ 126,983
Operating expenses    
Cost of products sold 124,874 229,696
Selling, general and administrative 823,254 433,330
Total Operating Expenses 948,128 663,026
Loss from operations (833,675) (536,043)
Interest expense – bank debt 337
Interest expense – shareholder 83,955
Loss on extinguishment of debt upon notes conversion 188,397
Change in derivative liability (207,524)
Interest expense – other 322,739
Other expense- non cash 19,877
Total other expense 407,781
Provision for income tax
Net loss (833,675) (943,824)
Deemed dividend on Series B Stock 289,935  
Net loss attributable to common shareholders $ (1,123,610) $ (943,824)
Basic and diluted net loss per common share (in Dollars per share) $ (0.01) $ (0.02)
Weighted average shares of capital outstanding – basic and diluted (in Shares) 82,394,547 63,442,930